MetaCap

Neumora Therapeutics (NMRA) News

NASDAQ: NMRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.3339-0.0131 (-3.78%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NMRA news summary

We found 2 recent headlines mentioning Neumora Therapeutics (NMRA): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, NMRA is down 3.78% at $0.3339. The most recent story, "Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Neumora Therapeutics headlines

Compare NMRA